Dine Brands Global has adopted a shareholder rights plan, commonly called a “poison pill,” designed to make it harder for an investor to build a large stake and gain control without the board’s involvement. The plan does not immediately change shareholders’ voting or dividend rights, and it is not expected to block a merger or other business combination approved by the board.
-
Who receives rights: Shareholders of record at the close of business on November 9, 2026, will receive one right for each outstanding common share. Rights will also attach to shares issued after that date until they separate from the stock or expire.
-
What each right provides: Subject to the plan’s terms, each right entitles its holder to buy one one-thousandth of a share of Series A junior participating preferred stock for $210, subject to adjustment. The rights initially travel with the common shares and cannot be exercised separately.
-
When the rights separate and become exercisable: Generally, separation occurs on the earlier of the 10th day after a person or group is publicly identified as having crossed the ownership threshold, or the 10th business day after the start of a tender or exchange offer that would cross it. The board may set a later date for the offer-related trigger.
-
Ownership thresholds: A non-passive investor or group generally crosses the threshold at 10% of the company’s common stock. For a passive investor, the threshold is 20%, for as long as the investor remains passive.
-
Existing large shareholders: Investors already at or above the relevant threshold when the plan was announced are generally grandfathered at their existing ownership level. That protection can be lost if they increase their holdings beyond a specified limit tied to their ownership level after the announcement.
-
Other provisions affecting the threshold: Certain derivative positions can count toward beneficial ownership based on their economic exposure when counterparties hold the corresponding shares. Purchases directly from Dine Brands, or through a board-approved underwritten offering, do not by themselves trigger the plan. The board may also allow an inadvertent threshold crossing to be corrected by prompt divestment.
-
Rights before separation: Until the rights separate, they transfer only with the underlying common shares. Once separated, they are represented separately. A right carries no voting or dividend rights before it is exercised.
-
Duration and early end points: The plan is scheduled to expire on October 27, 2027, but may end sooner if the company redeems or exchanges the rights, or when a board-approved merger or other acquisition closes—provided the agreement was approved before anyone became an acquiring person.
What changes for investors: The plan adds a potential barrier to an investor accumulating a substantial position without board engagement. It does not itself change the company’s ownership or hand control to a new party. The board retains authority over key aspects of the plan, including certain timing decisions and whether to redeem or exchange the rights.